Close

Karyopharm Therapeutics (KPTI) Announces Presentation of Selinexor Phase 2 Data; Lower Adverse Effects Noted

Go back to Karyopharm Therapeutics (KPTI) Announces Presentation of Selinexor Phase 2 Data; Lower Adverse Effects Noted